Indegene Limited IPO (Indegene IPO) Detail | 10 key things to know before subscribing
Here are 10 key things to know before subscribing to the offer:
1) IPO Dates
The IPO will open for subscription on 06 May 2024, and close on 08 May 2024.
2) Price Band
The price band for the issue has been fixed at Rs 430 – 452 per share. At the upper price band, the company’s valuation stands at Rs 20,283 crore.
3) Offer Details
An offer-for-sale (OFS) of 23,932,732 equity shares by the investor selling shareholder and a fresh issue of ₹760 crore make up the ₹1,841.76 crore Indegene IPO
4) Objectives of Issue
The proceeds of the fresh issue will be used by the company to finance inorganic growth, general corporate purposes, capital expenditure requirements for both the company and one of its material subsidiaries, Indegene, Inc, as well as the repayment or prepayment of ILSL Holdings, Inc’s debt
5) Lot Size
Minimum Investment : 14,916 / 1 Lot (33 Shares)
Maximum Quantity : 1,93,908 /13 Lots (429 Shares)
6) Company Profile
Indegene Limited, established in 1998, provides digital services for the life science industry. Their services can be divided into the following categories – Enterprise Commercial Solutions, Omnichannel Activation, Enterprise Medical Solutions, and Enterprise Clinical Solutions and Consultancy Services. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support. Their solutions enable life sciences companies to develop products, launch them in the market, and drive sales through their life cycle in a more effective, efficient, and modern manner.
7) Financials
The company reported 42.8 percent on-year growth in consolidated net profit at Rs 624 crore for the year ended March 2023 and a 25 percent rise in revenue from operations at Rs 4,414.2 crore during the same period. In the six-month period ended September FY24, profit surged 36 percent to Rs 351.9 crore and revenue increased by 34 percent to Rs 2,526.7 crore compared to year-ago period.
8) Lead Managers
The book running lead managers of the Indigene IPO are Nomura Financial Advisory And Securities (India) Pvt Ltd, Citigroup Global Markets India Private Limited, J.P. Morgan India Private Limited, and Kotak Mahindra Capital Company Limited.
9) Know before investing
Strength2
1.Expertise in digital commercialization is the key strength of the company.
2.Provides portfolio of solutions covering all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies.
Risk2
1.Business is heavily dependent on the life sciences industry, particularly biopharmaceutical, emerging biotech, and medical device companies.
2.The life sciences commercialization services sector is highly competitive which could lead to pricing pressures, loss of clients, or reduced market share.
10) Listing Date
The trading of Indegene Limited shares on the bourses will commence with effect from 13 May 2024, as per the IPO schedule.
Previous Post